• Je něco špatně v tomto záznamu ?

Synthetic structural modifications of neurosteroid pregnanolone sulfate: Assessment of neuroprotective effects in vivo

M. Chvojkova, L. Rambousek, H. Chodounska, E. Kudova, K. Vales

. 2020 ; 881 (-) : 173187. [pub] 20200521

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020259

Neuroactive steroid 20-oxo-5β-pregnan-3α-yl L-glutamyl 1-ester (PA-Glu), a synthetic analogue of naturally occurring 20-oxo-5β-pregnan-3α-yl sulfate (pregnanolone sulfate, PA-S), inhibits N-methyl-D-aspartate (NMDA) receptors and possesses neuroprotective properties and minimal adverse effects. Herein, we report in vivo effects of new structural modifications of the PA-S molecule: a nonpolar modification of the steroid D-ring (5β-androstan-3α-yl L-glutamyl 1-ester, AND-Glu), attachment of a positively charged group to C3 (20-oxo-5β-pregnan-3α-yl L-argininate dihydrochloride salt, PA-Arg) and their combination (5β-androstan-3α-yl L-argininate dihydrochloride salt, AND-Arg). The first aim of this study was to determine the structure-activity relationship for neuroprotective effects in a model of excitotoxic hippocampal damage in rats, based on its behavioral correlate in Carousel maze. The second aim was to explore side effects of neuroprotective steroids on motor functions, anxiety (elevated plus maze) and locomotor activity (open field) and the effect of their high doses in mice. The neuroprotective properties of PA-Glu and AND-Glu were proven, with the effect of the latter appearing to be more pronounced. In contrast, neuroprotective efficacy failed when positively charged molecules (PA-Arg, AND-Arg) were used. AND-Glu and PA-Glu at the neuroprotective dose (1 mg/kg) did not unfavorably influence motor functions of intact mice. Moreover, anxiolytic effects of AND-Glu and PA-Glu were ascertained. These findings corroborate the value of research of steroidal inhibitors of NMDA receptors as potential neuroprotectants with slight anxiolytic effect and devoid of behavioral adverse effects. Taken together, the results suggest the benefit of the nonpolar D-ring modification, but not of the attachment of a positively charged group to C3.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020259
003      
CZ-PrNML
005      
20210830101857.0
007      
ta
008      
210728s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejphar.2020.173187 $2 doi
035    __
$a (PubMed)32446713
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Chvojkova, Marketa $u Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic; National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic; 2nd Faculty of Medicine, Charles University, V Uvalu 84, 150 06, Prague 5 - Motol, Czech Republic. Electronic address: marketa.chvojkova@nudz.cz
245    10
$a Synthetic structural modifications of neurosteroid pregnanolone sulfate: Assessment of neuroprotective effects in vivo / $c M. Chvojkova, L. Rambousek, H. Chodounska, E. Kudova, K. Vales
520    9_
$a Neuroactive steroid 20-oxo-5β-pregnan-3α-yl L-glutamyl 1-ester (PA-Glu), a synthetic analogue of naturally occurring 20-oxo-5β-pregnan-3α-yl sulfate (pregnanolone sulfate, PA-S), inhibits N-methyl-D-aspartate (NMDA) receptors and possesses neuroprotective properties and minimal adverse effects. Herein, we report in vivo effects of new structural modifications of the PA-S molecule: a nonpolar modification of the steroid D-ring (5β-androstan-3α-yl L-glutamyl 1-ester, AND-Glu), attachment of a positively charged group to C3 (20-oxo-5β-pregnan-3α-yl L-argininate dihydrochloride salt, PA-Arg) and their combination (5β-androstan-3α-yl L-argininate dihydrochloride salt, AND-Arg). The first aim of this study was to determine the structure-activity relationship for neuroprotective effects in a model of excitotoxic hippocampal damage in rats, based on its behavioral correlate in Carousel maze. The second aim was to explore side effects of neuroprotective steroids on motor functions, anxiety (elevated plus maze) and locomotor activity (open field) and the effect of their high doses in mice. The neuroprotective properties of PA-Glu and AND-Glu were proven, with the effect of the latter appearing to be more pronounced. In contrast, neuroprotective efficacy failed when positively charged molecules (PA-Arg, AND-Arg) were used. AND-Glu and PA-Glu at the neuroprotective dose (1 mg/kg) did not unfavorably influence motor functions of intact mice. Moreover, anxiolytic effects of AND-Glu and PA-Glu were ascertained. These findings corroborate the value of research of steroidal inhibitors of NMDA receptors as potential neuroprotectants with slight anxiolytic effect and devoid of behavioral adverse effects. Taken together, the results suggest the benefit of the nonpolar D-ring modification, but not of the attachment of a positively charged group to C3.
650    _2
$a zvířata $7 D000818
650    _2
$a chování zvířat $x účinky léků $7 D001522
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a agonisté excitačních aminokyselin $x toxicita $7 D018690
650    _2
$a antagonisté excitačních aminokyselin $x chemická syntéza $x farmakologie $7 D018691
650    _2
$a hipokampus $x účinky léků $x metabolismus $x patologie $x patofyziologie $7 D006624
650    _2
$a lokomoce $x účinky léků $7 D008124
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a bludiště - učení $x účinky léků $7 D018782
650    _2
$a myši $7 D051379
650    _2
$a molekulární struktura $7 D015394
650    _2
$a pohybová aktivita $x účinky léků $7 D009043
650    _2
$a N-methylaspartát $x toxicita $7 D016202
650    _2
$a neuroprotektivní látky $x chemická syntéza $x farmakologie $7 D018696
650    _2
$a pregnanolon $x analogy a deriváty $x chemická syntéza $x farmakologie $7 D011280
650    _2
$a potkani Long-Evans $7 D020318
650    _2
$a receptory N-methyl-D-aspartátu $x antagonisté a inhibitory $x metabolismus $7 D016194
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a sírany $x chemická syntéza $x farmakologie $7 D013431
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rambousek, Lukas $u Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic
700    1_
$a Chodounska, Hana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 2, 166 10, Prague 6, Czech Republic
700    1_
$a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 2, 166 10, Prague 6, Czech Republic
700    1_
$a Vales, Karel $u Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic; National Institute of Mental Health, Topolova 748, 250 67, Klecany, Czech Republic
773    0_
$w MED00001641 $t European journal of pharmacology $x 1879-0712 $g Roč. 881, č. - (2020), s. 173187
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32446713 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101857 $b ABA008
999    __
$a ok $b bmc $g 1690940 $s 1140705
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 881 $c - $d 173187 $e 20200521 $i 1879-0712 $m European journal of pharmacology $n Eur J Pharmacol $x MED00001641
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace